A Ginestra

Author PubWeight™ 8.17^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro.	Clin Exp Metastasis	1999	1.46
2	Selective localization of matrix metalloproteinase 9, beta1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells.	Cancer Res	1998	1.33
3	Human breast carcinoma cells cultured in the presence of serum shed membrane vesicles rich in gelatinolytic activities.	J Submicrosc Cytol Pathol	1994	1.08
4	Ultrastructural and phenotypic characterization of CABA I, a new human ovarian cancer cell line.	Oncol Res	1997	0.94
5	Modulation of vesicle shedding in 8701 BC human breast carcinoma cells.	J Submicrosc Cytol Pathol	1998	0.89
6	Proteomic dissection of dome formation in a mammary cell line: role of tropomyosin-5b and maspin.	Proc Natl Acad Sci U S A	2001	0.88
7	Shed membrane vesicles and selective localization of gelatinases and MMP-9/TIMP-1 complexes.	Ann N Y Acad Sci	1999	0.86
8	Inhibitory effects of vesicles shed by human breast carcinoma cells on lymphocyte 3H-thymidine incorporation, are neutralised by anti TGF-beta antibodies.	J Submicrosc Cytol Pathol	1995	0.85
9	["Classic" vs autolubricant catheterization for endovesicular chemotherapy. Preliminary experience].	Minerva Urol Nefrol	1999	0.75
10	Relationship between dose, mode of administration and effects of triiodothyronine on two hepatic responsive enzymes.	Horm Metab Res	1995	0.75